Abstract
A 68-year-old Japanese male presented with atrophic erythematous white lesions with peripheral dark reddish rims on his back. Multiple ulcers were detected from his stomach to his large intestine using endoscopy. Although the patient was given high doses of a steroid, aspirin, dipyridamole, and intravenous immunoglobulin therapy, he died of gastrointestinal hemorrhage, perforation and septic shock. An autopsy examination revealed pauci-inflammatory thrombotic microangiopathy with endothelial cell injury, fibrous occlusive arteriopathy, and vascular C5b-9 deposition in the wall of the gastrointestinal tract from the esophagus to the large intestine as well as in the dermis of the skin.
Similar content being viewed by others
References
Beljaards RC, Starink TM, Meuwissen SG. 2 families with malignant atrophic papulosis (Degos disease) (in Dutch). Ned Tijdschr Geneeskd. 1988;132:269–71.
Durie BG, Stroud JD, Kahn JA. Progressive systemic sclerosis with malignant atrophic papulosis. Arch Dermatol. 1969;100:575–81.
Fernandez-Flores A, Manjon JA, Mencia J. Diabetes mellitus and Degos disease (published correction appears in Bratisl Lek Listy. 2008;109:533). Bratisl Lek Listy. 2008;109:414–7.
Snow JL, Muller SA. Degos syndrome: malignant atrophic papulosis. Semin Dermatol. 1995;14:99–105.
Doutre MS, Beylot C, Bioulac P, et al. Skin lesions resembling malignant atrophic papulosis in lupus erythematosus. Dermatologica. 1987;175:45–6.
Notash AY, Mazoochy H, Mirshams M, et al. Lethal systemic Degos disease with prominent cardio-pulmonary involvement. Saudi Med J. 2008;29:133–7.
High WA, Aranda J, Patel SB, et al. Is Degos’ disease a clinical and histological end point rather than a specific disease? J Am Acad Dermatol. 2004;50:895–9.
Megro CM, Poe JC, Kim C et al. Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome. Am J Clin Pathol. 2011;135:599–610.
Tsao H, Busam K, Barnhill RL, et al. Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. J Am Acad Dermatol. 1997;36:317–9.
Heymann WR. Degos disease: considerations for reclassification. J Am Acad Dermatol. 2009;61(3):505–06.
Kolb WP, Muller-Eberhard HJ. Neoantigens of the membrane attack complex of complement. Proc Natl Acad Sci USA. 1975;72:1687–9.
Kinoshita T. Biology of complement: the overture. Immunol Today. 1991;12:202–5.
Norris DA, Lee LA. Antibody-dependent cellular cytotoxicity and skin disease. J Invest Dermatol. 1985;85(1 suppl):165S–75S.
Norris DA, Ryan SB, Kissinger RM, Fritz KA, Boyce ST. Systematic comparison of antibody-mediated mechanisms of keratinocyte lysis in vitro. J Immunol. 1985;135:1073–9.
Norris DA. Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol. 1993;100:58S–68S.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Umemura, M., Miwa, Y., Yanai, R. et al. A case of Degos disease: demonstration of C5b-9-mediated vascular injury. Mod Rheumatol (2013). https://doi.org/10.1007/s10165-013-0888-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10165-013-0888-x